Viridian Therapeutics, Inc./DE
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $9.7M | $24.8M | $22.1M |
| FY2017 | $14.0M | $52.5M | $47.4M |
| FY2018 | $14.8M | $66.1M | $32.6M |
| FY2019 | $14.5M | $30.3M | $24.8M |
| FY2020 | $11.2M | $131.3M | $45.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $9.7M | $24.8M | $22.1M |
| FY2017 | $14.0M | $52.5M | $47.4M |
| FY2018 | $14.8M | $66.1M | $32.6M |
| FY2019 | $14.5M | $30.3M | $24.8M |
| FY2020 | $11.2M | $131.3M | $45.9M |